Literature DB >> 17291358

New developments in BCG vaccine: implications for tuberculosis control.

C R MacIntyre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17291358      PMCID： PMC2870579          DOI： 10.1017/S0950268806007126

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


× No keyword cloud information.
  29 in total

1.  The global tuberculosis situation and the new control strategy of the World Health Organization. 1991.

Authors:  A Kochi
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

2.  An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.

Authors:  D Smith; E Wiegeshaus; V Balasubramanian
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

3.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Authors:  Leander Grode; Peter Seiler; Sven Baumann; Jürgen Hess; Volker Brinkmann; Ali Nasser Eddine; Peggy Mann; Christian Goosmann; Silke Bandermann; Debbie Smith; Gregory J Bancroft; Jean-Marc Reyrat; Dick van Soolingen; Bärbel Raupach; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

4.  Evaluation of BCG vaccination among Puerto Rican children.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Public Health       Date:  1974-03       Impact factor: 9.308

5.  Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains.

Authors:  M Gheorghiu; P H Lagrange
Journal:  Ann Immunol (Paris)       Date:  1983 Jan-Feb

6.  Pathogenesis of tuberculosis and effectiveness of BCG vaccination.

Authors:  H G ten Dam; A Pio
Journal:  Tubercle       Date:  1982-09

7.  Recent advances in epidemiological research in tuberculosis.

Authors:  K Styblo
Journal:  Adv Tuberc Res       Date:  1980

8.  A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.

Authors:  A L Hersh; M Tala-Heikkilä; E Tala; A N A Tosteson; C Fordham von Reyn
Journal:  Int J Tuberc Lung Dis       Date:  2003-01       Impact factor: 2.373

9.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.

Authors:  G W Comstock; C Baum; D E Snider
Journal:  Am Rev Respir Dis       Date:  1979-05

10.  Trial of BCG vaccines in south India for tuberculosis prevention: first report--Tuberculosis Prevention Trial.

Authors: 
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408
View more
  1 in total

1.  Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.

Authors:  Julie A Chapeton-Montes; David F Plaza; Hernando Curtidor; Martha Forero; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Protein Sci       Date:  2007-12-20       Impact factor: 6.725
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.